Aarti Pharmalabs Ltd
Aarti Pharmalabs Ltd (AARTIPHARM) last traded at ₹834, a market capitalisation of ₹7,560 crore, on a P/E of 35.1. Over the past 52 weeks the stock has ranged between ₹584 and ₹946. Aarti Pharmalabs Ltd last reported results for the quarter ended Jun 2026, with sales of ₹536 crore and net profit of ₹76 crore. The next scheduled event is a record date on 15 Sept 2026. Figures are as of 25 Aug 2026 and are not real time.
Aarti Pharmalabs Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Aarti Pharmalabs Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹536 cr, up 38.9% from ₹386 cr a year earlier. Net profit was ₹76 cr, up 52.0% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 458 | 538 | 564 | 386 | 418 | 432 | 583 | 536 |
| Expenses | 364 | 409 | 418 | 293 | 344 | 330 | 470 | 400 |
| Operating profit | 94 | 129 | 146 | 93 | 74 | 102 | 113 | 136 |
| OPM % | 20% | 24% | 26% | 24% | 18% | 24% | 19% | 25% |
| Other income | 4 | 5 | -2 | 2 | 0 | 2 | 14 | 8 |
| Interest | 6 | 10 | 7 | 7 | 11 | 13 | 17 | 13 |
| Depreciation | 21 | 23 | 23 | 23 | 25 | 29 | 28 | 30 |
| Profit before tax | 72 | 101 | 115 | 65 | 39 | 63 | 82 | 101 |
| Tax % | 24% | 26% | 23% | 24% | 28% | 24% | 25% | 25% |
| Net profit | 55 | 74 | 88 | 50 | 28 | 48 | 61 | 76 |
| EPS (₹) | 6.03 | 8.16 | 9.75 | 5.46 | 3.08 | 5.29 | 6.74 | 8.40 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Aarti Pharmalabs Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 0 | 1,200 | 1,945 | 1,853 | 2,115 | 1,819 | 1,969 |
| Operating profit | 0 | 207 | 342 | 386 | 464 | 369 | 426 |
| OPM % | — | 17% | 18% | 21% | 22% | 20% | 22% |
| Net profit | 0 | 122 | 193 | 217 | 272 | 175 | 213 |
| EPS (₹) | — | — | 21.35 | 23.93 | 30.05 | 19.27 | 23.51 |
TTM is the trailing twelve months to the most recent quarter.
Aarti Pharmalabs Ltd growth and returns
- 10 Years
- %
- 5 Years
- %
- 3 Years
- -2%
- TTM
- 1%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- -3%
- TTM
- -19%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 29%
- 1 Year
- 2%
- 10 Years
- %
- 5 Years
- 13%
- 3 Years
- 12%
- Last Year
- 9%
Aarti Pharmalabs Ltd shareholding pattern
Promoters held 42.86% at Jun 2026, down from 43.72% at Jun 2025. FIIs 8.17% and DIIs 7.22%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 46.10% | 44.65% | 44.29% | 43.72% | 42.88% | 43.10% | 43.08% | 42.86% |
| FIIs | 7.38% | 8.64% | 7.36% | 7.34% | 8.02% | 7.69% | 8.39% | 8.17% |
| DIIs | 11.35% | 10.36% | 7.53% | 7.80% | 6.95% | 7.66% | 7.40% | 7.22% |
| Government | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Public | 35.17% | 36.33% | 40.81% | 41.12% | 42.12% | 41.54% | 41.10% | 41.74% |
| No. of shareholders | 1,85,436 | 1,85,111 | 1,96,314 | 1,87,039 | 1,90,655 | 1,84,489 | 1,79,373 | 1,76,506 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Upcoming Aarti Pharmalabs Ltd events
The next scheduled event is a record date on 15 Sept 2026.
- Record dateRecord date for final dividend payment of INR 2.00 per share
See the full results calendar for every Indian company reporting in the next 30 days.
Aarti Pharmalabs Ltd corporate filings
- Announcement under Regulation 30 (LODR)-Newspaper PublicationCompany Updatelow impact
Cruxal's analysis: Aarti Pharmalabs Ltd has submitted a routine disclosure under Regulation 30 of the SEBI…
Read the full analysis - Disclosure as enclosedCorp. Actionlow impact
Cruxal's analysis: Aarti Pharmalabs Limited has officially announced Tuesday, September 15, 2026, as the…
Read the full analysis - Q1 FY 27 Earnings Call TranscriptCompany Updatehigh impact
Cruxal's analysis: Aarti Pharmalabs reported strong Q1 FY27 standalone revenue of INR 535 crore, a 42% YoY…
Read the full analysis - Audio Recording of Conference Call for Investor and AnalystsCompany Updatelow impact
Cruxal's analysis: Aarti Pharmalabs Ltd has filed the audio recording of its conference call held with…
Read the full analysis - Q1 FY 2027 Investor PresentationCompany Updatehigh impact
Cruxal's analysis: Aarti Pharmalabs Limited reported strong Q1 FY27 consolidated financial performance with…
Read the full analysis - Newspaper Publication on Financial ResultsCompany Updatelow impact
Cruxal's analysis: Aarti Pharmalabs Limited has fulfilled its regulatory obligation under SEBI Listing…
Read the full analysis - As enclosedCompany Updatelow impact
Cruxal's analysis: Aarti Pharmalabs Limited has informed the exchanges that Mr. Rajendra Vallabhaji Gogri, a…
Read the full analysis - Disclosure as enclosedCompany Updatemedium impact
Cruxal's analysis: Aarti Pharmalabs has formally approved a capacity addition project focused on its…
Read the full analysis - Outcome of Board Meeting held on August 07, 2026.Board Meetinghigh impact
Cruxal's analysis: Aarti Pharmalabs Limited reported a robust performance for the quarter ended June 30…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Aarti Pharmalabs Ltd
Cruxal reads every Aarti Pharmalabs Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.